New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Zentalis Pharmaceuticals, Inc.
ZNTL
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

135M

Biotechnology

Next Earning date - 18 Mar 2025

135M

Biotechnology

Next Earning date - 18 Mar 2025

2.48USD

Shape0.05 ( 2.06%)
Market Closed (as of Feb 18, 21:00 EDT)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

-59%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

85%

Quote Panel

Shape
Updated March 18, 2025
1W -3.08 % 1M -25.30 % 3M -35.49 % 1Y -86.42 %

Key Metrics

Shape
  • Market Cap

    134.69M


  • Shares Outstanding

    71.27M


  • Share in Float

    53.59M


  • Dividende

    0


  • Earning Date

    18 Mar 2025


  • Price Target

    1.89


  • Average Volume

    1.86M


  • Beta

    1.754


  • Range

    1.61-16.265


  • Industry

    Biotechnology


  • Website

    https://zentalis.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

ZNTL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3M

ShapeNaN%

2025-Revenue

$2.52

Shape-349%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Wedbush

upgrade

Previous: Hold

2024-08-12

Now: Neutral

UBS

downgrade

Previous: Not converted

2024-06-20

Now: Neutral

Jefferies

downgrade

Previous: Not converted

2024-06-18

Now: Hold

Morgan Stanley

downgrade

Previous: Equal-Weight

2024-06-18

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.92
vs -1.11

Q1.23

arrow
arrow

N/A

-1.07
vs -1.31

Q2.23

arrow
arrow

N/A

-1.85
vs -1.34

Q3.23

arrow
arrow

N/A

-0.79
vs -0.96

Q4.23

arrow
arrow

N/A

-0.83
vs -0.92

Q1.24

arrow
arrow

+113%

0.14
vs -1.07

Q2.24

arrow
arrow

N/A

-1.24
vs -1.85

Q3.24

arrow
arrow

N/A

-0.56
vs -0.79

Q4.24

arrow
arrow

N/A

-0.69
vs -0.83

Q1.25

arrow
arrow

N/A

-0.63
vs 0.14

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

2.1M  vs NA

Q1.24

arrow
arrow

NA

40.6M  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-11%

-0.11
vs -0.12

Q1.23

arrow
arrow

-16%

-0.16
vs -0.11

Q2.23

arrow
arrow

-22%

-0.22
vs -0.16

Q3.23

arrow
arrow

-12%

-0.12
vs -0.22

Q4.23

arrow
arrow

-14%

-0.14
vs -0.12

Q1.24

arrow
arrow

+2%

0.02
vs -0.14

Q2.24

arrow
arrow

-23%

-0.23
vs 0.02

Q3.24

arrow
arrow

-11%

-0.11
vs -0.23

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

111

111
vs 108

3%

Q2.23

arrow
arrow

137

137
vs 111

23%

Q3.23

arrow
arrow

142

142
vs 137

4%

Q4.23

arrow
arrow

124

124
vs 142

-13%

Q1.24

arrow
arrow

143

143
vs 124

15%

Q2.24

arrow
arrow

146

146
vs 143

2%

Q3.24

arrow
arrow

138

138
vs 146

-5%

Q4.24

arrow
arrow

146

146
vs 138

6%

Earnings Growth

Latest News